Documentation Centre

 

 

  of 884 Next page

Go to page: of

Screenshot Date Categories Title Author Format
The crucial roles of apolipoproteins E and C-III in apoB lipoprotein metabolism in normolipidemia and hypertriglyceridemia. Curr Opin Lipidol. 2015;26:56-63 January 29, 2015 The crucial roles of apolipoproteins E and C-III in apoB lipoprotein metabolism in normolipidemia and hypertriglyceridemia. Curr Opin Lipidol. 2015;26:56-63 Sacks FM Key Publications
Dietary fatty acids, dietary patterns, and lipoprotein metabolism. Curr Opin Lipidol. 2015;26:42-7 January 28, 2015 Dietary fatty acids, dietary patterns, and lipoprotein metabolism. Curr Opin Lipidol. 2015;26:42-7 Lamarche B, Couture P Key Publications
Novel metabolic biomarkers of cardiovascular disease. Nat Rev Endocrinol. 2014;10:659-72 January 27, 2015 Novel metabolic biomarkers of cardiovascular disease. Nat Rev Endocrinol. 2014;10:659-72 Jensen MK, Bertoia ML, Cahill LE, Agarwal I, Rimm EB, Mukamal KJ Key Publications
Diabetes: saturated fatty acids--not all bad news. Nat Rev Endocrinol. 2014;10:639 January 26, 2015 Diabetes: saturated fatty acids--not all bad news. Nat Rev Endocrinol. 2014;10:639 Holmes D Key Publications
Relationships of plasma lipoprotein(a) levels with insulin resistance in hypertensive patients. Metabolism. 2014;63:1439-46 January 23, 2015 Relationships of plasma lipoprotein(a) levels with insulin resistance in hypertensive patients. Metabolism. 2014;63:1439-46 Marzano L, Colussi G, Del Torre M, Sechi LA, Catena C Key Publications
Favourable effects of fenofibrate on lipids and cardiovascular disease in women with type 2 diabetes: results from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Diabetologia. 2014;57:2296-303 January 16, 2015 Favourable effects of fenofibrate on lipids and cardiovascular disease in women with type 2 diabetes: results from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Diabetologia. 2014;57:2296-303 d'Emden MC, Jenkins AJ, Li L, Zannino D, Mann KP, Best JD, Stuckey BG, Park K, Saltevo J, Keech AC; FIELD Study Investigators Key Publications
Metabolomic biomarkers for obesity in humans: a short review. Ann Nutr Metab. 2014;64:314-24 January 15, 2015 Metabolomic biomarkers for obesity in humans: a short review. Ann Nutr Metab. 2014;64:314-24 Rauschert S, Uhl O, Koletzko B, Hellmuth C Key Publications
Obesity favors apolipoprotein E- and C-III-containing high density lipoprotein subfractions associated with risk of heart disease. J Lipid Res. 2014;55:2167-77 January 14, 2015 Obesity favors apolipoprotein E- and C-III-containing high density lipoprotein subfractions associated with risk of heart disease. J Lipid Res. 2014;55:2167-77 Talayero B, Wang L, Furtado J, Carey VJ, Bray GA, Sacks FM Key Publications
Lipoprotein insulin resistance index: a lipoprotein particle-derived measure of insulin resistance. Metab Syndr Relat Disord. 2014;12:422-9 January 08, 2015 Lipoprotein insulin resistance index: a lipoprotein particle-derived measure of insulin resistance. Metab Syndr Relat Disord. 2014;12:422-9 Shalaurova I, Connelly MA, Garvey WT, Otvos JD Key Publications
Lipid lowering with PCSK9 inhibitors. Nat Rev Cardiol. 2014;11:563-75 January 06, 2015 Lipid lowering with PCSK9 inhibitors. Nat Rev Cardiol. 2014;11:563-75 Dadu RT, Ballantyne CM Key Publications

  of 884 Next page

Go to page: of